NCT03847792View on ClinicalTrials.gov

Analgesic Effect Of Intra-articular Bupivacaine Fentanyl for Postoperative Pain Relief in Knee Arthroscopic Surgery

NACompletedINTERVENTIONAL
Enrollment

87

Participants

Timeline

Start Date

March 31, 2019

Primary Completion Date

May 30, 2020

Study Completion Date

June 30, 2020

Conditions
Knee Arthroscopic Surgery
Interventions
DRUG

Group DB/Dexamethasone-Bupivacaine

The patient were received an intra-articular injection of 18ml bupivacaine 0.25% added to 8mg dexamethasone.

DRUG

Group FB /Fentanyl-Bupivacaine

The patient were received an intra-articular injection of 1 ug/kg fentanyl added to 18ml of 0.25% bupivacaine.

DRUG

Group PB/Placebo-Bupivacaine

Patients were received an intra-articular injection of 2ml isotonic saline added to 18ml of 0.25% bupivacaine.

Trial Locations (2)

050

Mohamed A Sultan, Al Mansurah

Mansoura University, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03847792 - Analgesic Effect Of Intra-articular Bupivacaine Fentanyl for Postoperative Pain Relief in Knee Arthroscopic Surgery | Biotech Hunter | Biotech Hunter